- OREX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $18.9 million.
- OREX has traded 186,155 shares today.
- OREX is up 3.2% today.
- OREX was down 5.5% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in OREX with the Ticky from Trade-Ideas. See the FREE profile for OREX NOW at Trade-Ideas More details on OREX: Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products in the United States. The company offers Contrave for the treatment of obesity. Currently there are 6 analysts that rate Orexigen Therapeutics a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Orexigen Therapeutics has been 5.6 million shares per day over the past 30 days. Orexigen has a market cap of $868.7 million and is part of the health care sector and drugs industry. The stock has a beta of 2.23 and a short float of 35.3% with 11.37 days to cover. Shares are up 14.7% year-to-date as of the close of trading on Thursday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.